Task: Answer the multiple-choice question.
Question: Which drug exhibits a -13.305% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) COc1cccc(-n2c(SCC(=O)Nc3cc(C)on3)nc3c([nH]c4ccccc43)c2=O)c1
b.) O=C(Nc1ccc(Cl)cc1)c1cccnc1N1CCCCC1
c.) Cc1cccc(-c2noc(-c3cc4ccccc4oc3=O)n2)c1
Answer: b. O=C(Nc1ccc(Cl)cc1)c1cccnc1N1CCCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(Nc1ccc(Cl)cc1)c1cccnc1N1CCCCC1
O=C(Nc1ccc(Cl)cc1)c1cccnc1N1CCCCC1
N-(4-chlorophenyl)-2-piperidin-1-ylpyridine-3-carboxamide